Strados Labs reposted this
Enjoyed attending ATDC 2024 Graduation last night to celebrate Strados Labs! Richard Powers Jason Kroh Noah Cho Allison Sees Tom deLaubenfels
Strados Labs is a medical technology company focused on improving the lives of patients with respiratory diseases. Strados Labs' RESP® Biosensor is the first FDA 510(k) cleared wearable device that continuously captures lung sound symptoms such as coughing and wheezing in daily life. Our award-winning technology allows clinicians and researchers to enhance their understanding of how patients respond to treatment plans and therapies, enabling better care in healthcare settings and stronger evidence in drug development.
External link for Strados Labs
1315 Walnut Street
Suite 1101
Philadelphia, Pennsylvania 19107, US
715 Peachtree St NE
Atlanta, Georgia 30308, US
Strados Labs reposted this
Enjoyed attending ATDC 2024 Graduation last night to celebrate Strados Labs! Richard Powers Jason Kroh Noah Cho Allison Sees Tom deLaubenfels
As Respiratory Care Week comes to a close, we'd like to do a special shoutout to Rachel Hollatz, RRT - our talented Annotation Manager and registered respiratory therapist who seamlessly leads Strados Labs' lung sound annotation and analysis efforts. We would also like to thank our entire respiratory therapist and annotation team that Rachel leads. Because of this team's dedication and expertise, our clients receive clinically accurate, detailed reports of patients' cough and lung sounds. Thank you for helping #makeeverybreathcount, and another special thanks to all respiratory therapists for all you do for patients worldwide! #RCWEEK24 #respiratorytherapy #RTs #employeeappreciation
Many thanks to all of the panelists for a dynamic, engaging discussion earlier on decentralized clinical trials (DCTs). Fantastic takeaways and insights for sponsors on the advantages of DCTs, real-life challenges and implications, and key success factors. Thank you Nexus Conference for organizing the session! Nadia Niemeryanski, Prachi Dalal, MS, MBA, CCRP, Lorraine Fay, innes meldrum Nick Delmonico #clinicaltrials #nexusconference #DCTs #technology
Today is the day! Join us as our CEO, Nick Delmonico, moderates the session, "The Role of Decentralized Clinical Trials and Digitalization: Bridging the Gap in Modern Clinical Research," from 11:40 am to 12:15 pm at the Nexus Conference main stage. The esteemed panel of clinical operations leaders includes innes meldrum, Nadia Niemeryanski, Ashlyn Rose, Prachi Dalal, MS, MBA, CCRP, and Lorraine Fay. We’re excited to dive into how digital innovations are reshaping clinical trials and enhancing patient experiences. Don't miss this chance to engage in a meaningful discussion with industry experts! #clinicaltrials #biopharma #digitalhealth #patientcentricity #NexusClinical
The 21st BioPharma Clinical Trials Nexus by Nexus Conference starts today! Our team including Nick Delmonico, Shane Krauss, and Devan Parson, MBA will connect with industry leaders on-site and share insights on the latest advancements in cough monitoring, clinical trials and digital health. This is a fantastic opportunity to collaborate and explore innovative solutions that enhance patient-centricity in clinical research. If you're attending, please message us to connect! #clinicaltrials #biopharma #digitalhealth #patientcentricity #NexusClinical
Celebrating Respiratory Care Week 2024! This week we recognize respiratory therapists (RTs) who are dedicated to helping patients all over the world breathe easier. Whether they’re working in hospitals, clinics, diagnostic labs or patients' homes, RTs play a crucial role in respiratory care and our healthcare system. Thank you to all the respiratory therapists for all you do and the difference you make for patients every day! #RCWEEK24 #RTs #respiratorycare #RespiratoryTherapists #HealthcareHeroes
We’re excited to welcome Holly L. Davis, who has joined us as our Senior Quality Manager! With over 20 years of experience in quality assurance, regulatory compliance, and strategic planning in medical devices and other sectors, Holly is a dynamic change agent. Holly most recently worked at Abbott. Her expertise in developing quality management programs and enhancing product quality will be invaluable as we advance our mission. Holly studied Biochemistry at Georgia Tech and holds a Chemistry degree from the University of Georgia. Her extensive experience positions her to make a significant impact on our team. #qualitymanagement #newemployee #StradosLabs
We’re counting down to the 21st BioPharma Clinical Trials Nexus sponsored by Nexus Conference on October 22-23 in Somerset, NJ! Our CEO, Nick Delmonico, will be moderating a session titled "The Role of Decentralized Clinical Trials and Digitalization: Bridging the Gap in Modern Clinical Research" on October 23rd from 11:40 am to 12:15 pm. Join us to explore how digital innovations are transforming clinical trials and enhancing patient engagement. It’s an exciting opportunity to discuss the future of clinical operations! #clinicaltrials #biopharma #digitalhealth #patientcentricity #NexusClinical
Our recent blog, authored by Annotation Manager, Rachel Hollatz, dives deep into understanding lung sounds associated with COPD. These adventitious sounds, like wheezing and crackles, are vital indicators of airflow obstruction, lung fluid, and inflammation. The blog discusses how identifying these sounds can aid in diagnosis, treatment, and proactive management. Rachel also highlights the limitations of traditional auscultation and the benefits of continuous monitoring through wearables, such as our RESP® Biosensor, offering more comprehensive insights into patient health beyond clinical visits. Explore the blog for an in-depth look: https://lnkd.in/eqKUYcmM #COPD #pulmonarycare #respiratoryhealth #healthcareinnovation #wearabletech
Strados Labs reposted this
How can you build confidence in a groundbreaking device? By making the regulatory journey crystal clear. 💡 Strados Labs is transforming respiratory care with their innovative RESP® Biosensor, a wearable technology that tracks critical symptoms like cough and wheeze for conditions like COPD and asthma. However, when it came to working with clinical trial teams, they faced a challenge: How to effectively communicate the extensive validation and regulatory clearances of their device. 📔 That’s where DiMe’s The Playbook: Digital Clinical Measures came in. By leveraging The Playbook, Strados Labs clearly demonstrated the regulatory framework and clinical validation behind RESP® Biosensor. As a result, clinical trial teams gained the confidence needed to integrate this cutting-edge technology into their studies, accelerating the path to better patient outcomes. Discover how Strados Labs bridged the communication gap and set the stage for greater adoption of their RESP® technology. 💪 As Strados Labs continues to advance respiratory health through innovative solutions, The Playbook will remain a crucial resource, guiding them in their mission to enhance patient outcomes and improve the quality of life for those living with chronic respiratory diseases. 📖 Read the DiMe deep dive here: https://bit.ly/4erFv9u